Literature DB >> 25677823

QRFP-43 inhibits lipolysis by preventing ligand-induced complex formation between perilipin A, caveolin-1, the catalytic subunit of protein kinase and hormone-sensitive lipase in 3T3-L1 adipocytes.

Mukandila Mulumba1, Riccarda Granata2, Sylvie Marleau1, Huy Ong3.   

Abstract

QRFP (RFamide) peptides are neuropeptides involved in food intake and adiposity regulation in rodents. We have previously shown that QRFP-43 (43RFa) and QRFP-26 (26RFa) inhibited isoproterenol (ISO)-induced lipolysis in adipocytes. However, the antilipolytic signaling pathways activated by QRFP peptides have not been investigated. In the present study, 3T3-L1 adipocytes were used to identify the main pathways involved in QRFP-43 decreasing ISO-induced lipolysis. Our results show that QRFP-43 reduced ISO-induced phosphorylation of perilipin A (PLIN) and hormone-sensitive lipase (HSL) on Ser660 by 43 and 25%, respectively, but increased Akt phosphorylation by 44%. However, the inhibition of phosphodiesterase 3B (PDE3B), a regulator of lipolysis activated by Akt, did not reverse the antilipolytic effect of QRFP-43. PDE3B inhibition reversed the decrease of Ser660 HSL phosphorylation associated with QRFP-43 antilipolytic effect. QRFP-43 also prevented PKC activation and ISO-induced Src kinases activation leading to the inhibition of the caveolin-1 (CAV-1) translocation on lipid droplets. Indeed, QRFP-43 attenuated phorbol 12-myristate 13-acetate-induced lipolysis and ISO-induced extracellular signal-regulated and Src kinases by 28, 37 and 48%, respectively. The attenuation of ISO-induced lipolysis by QRFP-43 was associated with a decrease of phosphorylated Ser660 HSL, PKA-catalytic (PKA-c) subunit and CAV-1 translocation on lipid droplets by 37, 50 and 46%, respectively. The decrease in ISO-induced CAV-1 and PKA-c translocation was associated with a reduction of PLIN phosphorylation by 44% in QRFP-43-treated adipocytes. These results suggest that QRFP-43 attenuated ISO-induced lipolysis by preventing the formation of an active complex on lipid droplets and the activation of Src kinases and PKC.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Adipocytes; Adrenergic receptors; Caveolins; Lipolysis; Protein kinases; RFamide peptides

Mesh:

Substances:

Year:  2015        PMID: 25677823     DOI: 10.1016/j.bbalip.2015.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR Review 24.

Authors:  Jérôme Leprince; Didier Bagnol; Ronan Bureau; Shoji Fukusumi; Riccarda Granata; Shuji Hinuma; Dan Larhammar; Stefany Primeaux; Jana Sopkova-de Oliveiras Santos; Kazuyoshi Tsutsui; Kazuyoshi Ukena; Hubert Vaudry
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

2.  miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.

Authors:  Mennatallah Mamdouh Mahdy; Nada Magdy El-Ekiaby; Rana Mahmoud Hashish; Radwa Ayman Salah; Rasha Sayed Hanafi; Hassan Mohamed Azzazy; Ahmed Ihab Abdelaziz
Journal:  J Clin Transl Hepatol       Date:  2016-12-26

3.  Shared genetic loci for body fat storage and adipocyte lipolysis in humans.

Authors:  Agné Kulyté; Veroniqa Lundbäck; Peter Arner; Rona J Strawbridge; Ingrid Dahlman
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

Review 4.  The Neuropeptide 26RFa (QRFP) and Its Role in the Regulation of Energy Homeostasis: A Mini-Review.

Authors:  Nicolas Chartrel; Marie Picot; Mouna El Medhi; Arnaud Arabo; Hind Berrahmoune; David Alexandre; Julie Maucotel; Youssef Anouar; Gaëtan Prévost
Journal:  Front Neurosci       Date:  2016-11-29       Impact factor: 4.677

Review 5.  Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function.

Authors:  Iacopo Gesmundo; Tania Villanova; Dana Banfi; Giacomo Gamba; Riccarda Granata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-03       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.